An innovative study employing sgp130Fc (a soluble form of gp130 that binds IL-6/sIL-6R complexes and prevents them from signaling) inhibited the development of hypertension, but not vascular hypertrophy [73]. The gene discussed is IL6; the disease is hypertensive disorder.